HAIMO(SZ:300084)2020-04-24 16:00Financial Performance - Total revenue for Q1 2020 was ¥48,792,903.95, a decrease of 45.32% compared to ¥89,234,952.24 in the same period last year[7] - Net profit attributable to shareholders was -¥27,925,551.35, representing a decline of 50.83% from -¥18,514,356.38 year-on-year[7] - Basic and diluted earnings per share were both -¥0.0726, a decrease of 50.94% from -¥0.0481 in the same period last year[7] - The company's operating revenue for the reporting period was 48.79 million, a decrease of 45.32% compared to the same period last year[18] - The net profit attributable to shareholders was -27.93 million, an increase in loss of 944.12 thousand compared to the previous year[18] - The company reported a total comprehensive loss of CNY 26,217,361.89 for Q1 2020, compared to a loss of CNY 29,947,103.53 in the same period last year[41] Cash Flow - The net cash flow from operating activities improved by 67.42%, reaching -¥5,696,987.68 compared to -¥17,484,738.18 in the previous year[7] - Cash inflow from operating activities was 155,627,320.31 RMB, down from 171,874,007.84 RMB in the previous period, representing a decrease of approximately 9.5%[47] - The net cash flow from operating activities was -5,696,987.68 RMB, an improvement from -17,484,738.18 RMB in the previous period[48] - Cash outflow from investing activities totaled 50,992,220.80 RMB, compared to 89,991,149.75 RMB in the previous period, indicating a reduction of about 43.4%[48] - The net cash flow from financing activities was -27,214,737.51 RMB, a significant decline from 34,275,109.65 RMB in the previous period[49] Assets and Liabilities - Total assets at the end of the reporting period were ¥3,061,224,319.89, down 2.70% from ¥3,146,147,490.25 at the end of the previous year[7] - Current assets decreased from ¥1,636,371,922.51 to ¥1,554,255,623.58, a decline of approximately 5%[30] - Total liabilities decreased from ¥1,220,004,143.55 to ¥1,160,866,876.38, a reduction of about 4.9%[32] - The company's total liabilities decreased to CNY 903,650,926.53 from CNY 947,823,729.47[36] - The company's equity attributable to shareholders decreased from ¥1,905,511,783.85 to ¥1,880,067,648.12, a decrease of about 1.3%[33] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 22,780[10] - The largest shareholder, Dou Jianwen, holds 17.86% of the shares, with 68,736,810 shares, of which 51,552,607 are pledged[10] - The company did not engage in any repurchase transactions among the top 10 shareholders during the reporting period[11] Government Support and Subsidies - The company received government subsidies amounting to ¥1,574,762.00 during the reporting period[8] Investment and R&D - Research and development expenses for Q1 2020 were CNY 5,800,004.21, a decrease from CNY 6,762,343.88 year-over-year[39] - The company has implemented cost reduction and efficiency enhancement measures in response to the impact of the COVID-19 pandemic[18] - The company has focused resources on the "fracturing return liquid treatment" related projects, reducing fixed asset investments in less profitable areas[22] Market Conditions and Risks - The company is facing risks related to global COVID-19 pandemic impacts, affecting order delivery and procurement efficiency[18] - The company has adjusted its investment scale in response to market conditions, which has led to a significant reduction in expected market benefits from certain projects[22]